Device Trial Radar · NCT01139814
Clinical Study to Evaluate the Catheter Robotics Amigo for Performing Right-Sided Electrophysiology Mapping Studies
Last checked: Nov 20, 2026Latest source record: Apr 11, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- Catheter Robotics, Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Medpace, Inc.
- First posted
- Jun 9, 2010
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical study is to collect safety and performance data to support a demonstration of substantial equivalence of the Catheter Robotics Remote Catheter System to predicate devices when used to perform EP mapping of the right heart (atrium and ventricle).
Conditions
- Atrial Flutter
- Ventricular Tachycardia
Interventions
Amigo catheter robotDevice
The Amigo Catheter System is intended to facilitate manipulation, positioning and control of a Diagnostic Catheter.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Navigation PerformanceTime frame: During Procedure
1 more outcomes with a free account
Locations
12 sites in 2 countries. Site status is shown where the registry gives one.
Hoag Memorial Hospital Presbyterian
Newport Beach, California
11 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.